Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
634
-
Total 13F shares, excl. options
-
83.9M
-
Shares change
-
-8.4M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$1.76B
-
Put/Call ratio
-
0.73
-
Number of buys
-
284
-
Number of sells
-
-360
-
Price
-
$147.87
Significant Holders of RESMED INC - COM (RMD) as of Q3 2023
797 filings reported holding RMD - RESMED INC - COM as of Q3 2023.
RESMED INC - COM (RMD) has 634 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.9M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (17.6M shares), BlackRock Inc. (12.1M shares), STATE STREET CORP (6.16M shares), FMR LLC (3.81M shares), GEODE CAPITAL MANAGEMENT, LLC (3.39M shares), Invesco Ltd. (2.01M shares), CITADEL ADVISORS LLC (1.72M shares), NORTHERN TRUST CORP (1.49M shares), NORGES BANK (1.3M shares), and Bank of New York Mellon Corp (1.14M shares).
This table shows the top 634 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.